|

Nivo800 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: nivolumab

Pipeline

Phase 1: 1

Top Sponsors

  • Vanderbilt-Ingram Cancer Center1

Indications

  • Squamous Cell Carcinoma (SCC)1
  • Squamous Cell Cancer of the Head and Neck1
  • Squamous Carcinoma Poorly Differentiated1
  • Squamous Carcinoma1
  • Squamous Cell Carcinoma Mouth1

Nashville, Tennessee1 trial

Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

Vanderbilt University Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.